Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Annual Meeting / Reverse Split WARNING...?
4
Mar 08, 2016 01:28PM
4
Mar 08, 2016 05:29PM
The current 400M shares become 40M at 10:1 BUT they are not changing the maximum of 600M which means they can then issue another 560M (all numbers rounded). Normally one would expect a company to reduce that maximum in the same ratio. But the BoD and thus PTSC is not doing the "normal" thing. Please read my initial posts. If someone can prove me wrong let me know. The Proxy in or around pages 14-15 takes the time to explain that the 600M limit is not being reduced. There's a reason for having to state that.
Share
New Message
Please login to post a reply